Evolution of drug regulations and regulatory innovation for anticancer drugs in China

Over the past two decades, China has introduced significant changes to drug regulations through regulatory innovations to accelerate drug review and approvals, keeping in line with the rapidly growing scientific innovation in drug research and development (R&D). In this study, we outlined the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yang, Zhang, Ning, Xie, Cuicui, Jiang, Yale, Qin, Yunhe, Zhou, Liyun, Fan, Yi, Ren, Lianjie, Yin, Chen, Yang, Huan, Xie, Wei, Zhai, Qing, Li, Guanqiao, Chen, Hongzhuan, Chen, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Policy Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764065/
https://www.ncbi.nlm.nih.gov/pubmed/36561995
http://dx.doi.org/10.1016/j.apsb.2022.08.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764065/
https://www.ncbi.nlm.nih.gov/pubmed/36561995
http://dx.doi.org/10.1016/j.apsb.2022.08.004

Ejemplares similares